Literature DB >> 6876052

Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination.

J A Ledermann, B I Hoffbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6876052      PMCID： PMC1439102          DOI： 10.1177/014107688307600717

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  13 in total

1.  Suppression of the arthus reaction in the guinea-pig by dapsone.

Authors:  D M Thompson; R Souhami
Journal:  Proc R Soc Med       Date:  1975-05

2.  Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies, and successful treatment with dapsone.

Authors:  S I Katz; J I Gallin; K C Hertz; A S Fauci; T J Lawley
Journal:  Medicine (Baltimore)       Date:  1977-09       Impact factor: 1.889

3.  [Measles vaccination and Schönlein-Henoch purpura].

Authors:  P Mastroiacovo
Journal:  Minerva Pediatr       Date:  1976-08-04       Impact factor: 1.312

4.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.

Authors:  O Stendahl; L Molin; C Dahlgren
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

5.  Studies on a patient with leucocytoclastic vasculities 'pyoderma gangrenosum' and paraproteinaemia.

Authors:  D M Thompson; R A Main; J S Beck; F Albert-Recht
Journal:  Br J Dermatol       Date:  1973-02       Impact factor: 9.302

6.  Erythema elevatum diutinum: an unusual reaction to streptococcal antigen and response to dapsone.

Authors:  J J Cream; G M Levene; C D Calnan
Journal:  Br J Dermatol       Date:  1971-05       Impact factor: 9.302

7.  Erythema elevatum diutinum--vesicular lesions and sulphone response.

Authors:  D I Vollum
Journal:  Br J Dermatol       Date:  1968-03       Impact factor: 9.302

8.  Vaccination and Henoch-Schoenlein purpura.

Authors:  J M Lane
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

9.  Allergic vasculitis(tri-symptom of Gougerot) treated with dapsone.

Authors:  G C Wells
Journal:  Proc R Soc Med       Date:  1969-07-07

10.  Sulfones and sulfonamides in dermatology today.

Authors:  P G Lang
Journal:  J Am Acad Dermatol       Date:  1979-12       Impact factor: 11.527
View more
  7 in total

Review 1.  Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.

Authors:  Céline Roman; Bogdan Dima; Laurence Muyshont; Thierry Schurmans; Olivier Gilliaux
Journal:  Eur J Pediatr       Date:  2019-06-22       Impact factor: 3.183

2.  Dapsone in Henoch-Schönlein purpura--worth a trial.

Authors:  B I Hoffbrand
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

3.  Cutaneous vasculitis presenting on the penis.

Authors:  N P Burrows; C Sonnex; S O Roberts; C A Carne
Journal:  Genitourin Med       Date:  1993-08

4.  Dapsone in Henoch-Schönlein purpura.

Authors:  P S Sarma
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

5.  Schönlein-Henoch purpura during pregnancy with successful outcome for mother and newborn.

Authors:  Robert Feldmann; Walter Rieger; Paul G Sator; Friedrich Gschnait; Friedrich Breier
Journal:  BMC Dermatol       Date:  2002-01-30

6.  Treatment of refractory IgA vasculitis with dapsone: a systematic review.

Authors:  Keum Hwa Lee; Sung Hwi Hong; Jinhae Jun; Youngheun Jo; Woogyeong Jo; Dayeon Choi; Jeongho Joo; Guhyun Jung; Sunghee Ahn; Andreas Kronbichler; Michael Eisenhut; Jae Il Shin
Journal:  Clin Exp Pediatr       Date:  2019-09-24

7.  A case of refractory Henoch-Schönlein purpura treated with thalidomide.

Authors:  Soo Jeong Choi; Sung Kyu Park; Wan Sik Uhm; Dae Sik Hong; Hee Sook Park; Young Lip Park; Kye Won Kwon
Journal:  Korean J Intern Med       Date:  2002-12       Impact factor: 2.884
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.